Putnam Investments’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-95,777
Closed -$4.91M 855
2021
Q1
$4.91M Buy
95,777
+9,564
+11% +$575K 0.01% 496
2020
Q4
$5.34M Buy
86,213
+13,706
+19% +$785K 0.01% 486
2020
Q3
$3.97M Buy
72,507
+51,082
+238% +$2.75M 0.01% 523
2020
Q2
$1.23M Buy
+21,425
New +$1.17M ﹤0.01% 739
2017
Q2
Sell
-29,800
Closed -$217K 1343
2017
Q1
$217K Sell
29,800
-205,684
-87% -$1.48M ﹤0.01% 1214
2016
Q4
$1.74M Buy
235,484
+34,484
+17% +$248K ﹤0.01% 874
2016
Q3
$1.21M Hold
201,000
﹤0.01% 976
2016
Q2
$902K Hold
201,000
﹤0.01% 1115
2016
Q1
$500K Hold
201,000
﹤0.01% 1244
2015
Q4
$1.63M Hold
201,000
﹤0.01% 1028
2015
Q3
$1.22M Hold
201,000
﹤0.01% 1121
2015
Q2
$1.65M Hold
201,000
﹤0.01% 1111
2015
Q1
$1.52M Hold
201,000
﹤0.01% 1116
2014
Q4
$1.37M Hold
201,000
﹤0.01% 1133
2014
Q3
$904K Hold
201,000
﹤0.01% 1230
2014
Q2
$1.18M Hold
201,000
﹤0.01% 1156
2014
Q1
$1.33M Buy
201,000
+1,000
+0.5% +$6.95K ﹤0.01% 1147
2013
Q4
$1.16M Hold
200,000
﹤0.01% 1171
2013
Q3
$1.11M Hold
200,000
﹤0.01% 1195
2013
Q2
$2.83M Buy
+200,000
New +$2.59M 0.01% 929

Other funds holding CCXI

Putnam Investments's CCXI Position: Q2 2021 in Review

Putnam Investments sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 95,777 shares — an estimated $4.91M sold.

Putnam Investments first reported a position in CCXI in Q2 2013 and held it in 20 quarters. The position peaked at $5.34M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Putnam Investments reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Putnam Investments sold 95,777 ChemoCentryx, Inc. shares in Q2 2021, an estimated $4.91M.
  • Putnam Investments first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 20 quarters.
  • Putnam Investments's ChemoCentryx, Inc. position peaked at $5.34M in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.